Agencies testify at House hearing on COVID-19 response
The House Energy and Commerce Committee today held a hearing on the administration’s response to the COVID-19 pandemic, which featured officials from the Department of Health and Human Services, National Institute of Allergy and Infectious Diseases, Food and Drug Administration, and Centers for Disease Control and Prevention.
NIAID Director Anthony Fauci, M.D., said the agency is supporting development of several SARS-CoV-2 vaccine candidates, including one by Moderna Inc. that could enter a phase 3 trial by July pending positive results in Phase 2. CDC Director Robert Redfield, M.D., also said the agency continues to work with states and communities to expand COVID-19 testing and contact tracing.
Related News Articles
Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…